Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo C49 English + 你好 (nǐ hǎo) = limitless possibilities. Start learning Mandarin Chinese today—for free, forever. Amedeo C49 is completely free, for life. Next week: +49.

HIV Infection

Free Subscription Articles published in J Med Virol Retrieve available abstracts of 107 articles: HTML format

Single Articles

October 2025
1. HE J, Tian T, Tuo X, Yu W, et al
   Determinants of Changes in HPV Vaccination Willingness Among Men Who Have Sex With Men: An Observational Cohort Study.
   J Med Virol. 2025;97:e70611.
   PubMed     Abstract available
   
   
   
2. SHI S, Zhai M, Wu B, Sun W, et al
   Mitochondrial Disruption in Viral-Mediated Neuronal Injury: A Mechanistic Perspective.
   J Med Virol. 2025;97:e70626.
   PubMed     Abstract available
   
   
   September 2025
3. BERTONI C, Diotallevi S, Lolatto R, Piromalli G, et al
   Hepatitis B Viral Rebound in People With HIV Under HBV-Active Antiretroviral Therapy.
   J Med Virol. 2025;97:e70573.
   PubMed     Abstract available
   
   
   
4. POLITA D, de Moraes L, Giovanetti M, Rego FFA, et al
   South-to-Southeast Expansion of HIV-1 Subtype C in Brazil.
   J Med Virol. 2025;97:e70580.
   PubMed     Abstract available
   
   
   
5. PRATES G, Li X, Folgosi V, Souza G, et al
   Persistent Human T-Lymphotropic Virus Type 1 (HTLV-1) Infection in the Placenta of Pregnant Women.
   J Med Virol. 2025;97:e70585.
   PubMed     Abstract available
   
   
   
6. GALARZA P, Aguerre L, Procopio D, Krogh DH, et al
   Frequency of the CCR5Delta32 Variant in Haematopoietic Progenitor Cell Donors From Argentina: Implications for Transplantation in HIV-1 Infected Patients.
   J Med Virol. 2025;97:e70591.
   PubMed     Abstract available
   
   
   
7. BOUCHER J, Bazie WW, Goyer B, Alary M, et al
   HIV-1 RNA in Large and Small Plasma Extracellular Vesicles: A Novel Parameter for Monitoring Immune Activation and Virological Failure.
   J Med Virol. 2025;97:e70574.
   PubMed     Abstract available
   
   
   
8. XIONG X, Yao Y, Li Y, Jiang Y, et al
   Global Burden and Economic Impact of HIV/AIDS and Other Sexually Transmitted Infections in Women of Childbearing Age, 1990-2021: Insights From the GBD 2021 Study.
   J Med Virol. 2025;97:e70599.
   PubMed     Abstract available
   
   
   
9. VILLOSLADA A, Rodriguez A, Sorni P, Serrano A, et al
   The Role of Human Papillomavirus Genotypes on Anal Squamous Intraepithelial Lesions Among Gay, Bisexual and Other Men Who Have Sex With Men Living With HIV: Beyond HPV-16.
   J Med Virol. 2025;97:e70596.
   PubMed     Abstract available
   
   
   
10. YALCIN D, Eymard ED, Kiran K, Kibanga W, et al
    Insights Into Kaposi Sarcoma-Associated Herpesvirus-Specific Humoral Responses.
    J Med Virol. 2025;97:e70597.
    PubMed     Abstract available
    
    
    August 2025
11. PETAT H, Moisan A, Dubus C, Chabut M, et al
    Shifting Viral Landscapes: The Impact of Respiratory Syncytial Virus Immunization in Infant Bronchiolitis During 2024-2025 Epidemic Season in France.
    J Med Virol. 2025;97:e70515.
    PubMed    
    
    
    
12. ZULIAN V, Pauciullo S, Colombo D, McKay-Chopin S, et al
    Co-Infection Patterns of Beta, Gamma, and Alpha HPV Types in Cervical and Anal Sites in HIV-Positive Women.
    J Med Virol. 2025;97:e70518.
    PubMed     Abstract available
    
    
    
13. PAN D, Nazareth J, Bird PW, Musse U, et al
    Interpreting the Presence of EBV DNA in CSF Samples.
    J Med Virol. 2025;97:e70517.
    PubMed    
    
    
    
14. LIN L, Liu J, Zheng L, Zhang H, et al
    Kaposi Sarcoma-Associated Herpesvirus and Kidney Disease.
    J Med Virol. 2025;97:e70525.
    PubMed     Abstract available
    
    
    
15. SHRESTHA P, Treco EN, Davis DA, Yarchoan R, et al
    Novel Cereblon-Binding Immunomodulators Have Increased Potency Against Gammaherpesvirus- Associated Lymphomas In Vitro.
    J Med Virol. 2025;97:e70537.
    PubMed     Abstract available
    
    
    
16. LI F, Zhao W, Liu H, Niu Y, et al
    Single-Cell Omics Analysis Reveals Immunological Dysregulation in COVID-19 and HIV: Identifying a Shared Abnormality of B Cell Activation via the Unfolded Protein Response and Diagnostic Biomarkers Using Machine Learning Algorithms.
    J Med Virol. 2025;97:e70538.
    PubMed     Abstract available
    
    
    
17. CHEN SC, Lee YT
    Reframing HIV Diagnostic Delay: Silent Risk Indicators and Structural Gaps in Australia's Evolving Epidemic.
    J Med Virol. 2025;97:e70555.
    PubMed    
    
    
    July 2025
18. PANG X, He Q, Huang J, Tang K, et al
    Epidemiological Trends and CD4+T Cell Recovery in HIV-1 Patients With HCV/HBV Co-Infection: A Retrospective Cohort Study in Southwest China (2003-2024).
    J Med Virol. 2025;97:e70465.
    PubMed     Abstract available
    
    
    
19. MADSEN KL, Tranberg M, Norgaard P, Medina C, et al
    Feasibility of First-Void Urinary and Vaginal Self-Sampling for High-Risk Human Papillomavirus Testing Among Women Living With Human Immunodeficiency Virus in Guinea-Bissau-A Multicenter Cross-Sectional Study.
    J Med Virol. 2025;97:e70466.
    PubMed     Abstract available
    
    
    
20. MARSHALL VA, Knights SM, Cornejo Castro EM, Labo N, et al
    Kaposi Sarcoma-Associated Herpesvirus Sequencing in People Living With HIV in the Southern United States Reveals Subtype Diversity and Multiple Infections.
    J Med Virol. 2025;97:e70467.
    PubMed     Abstract available
    
    
    
21. CALLE-JIMENEZ O, Casado-Fernandez G, Armenteros-Yeguas I, Lemus-Aguilar L, et al
    Low Specific T-Cell Immunity Against Mpox Elicited in People With HIV-1 and PrEP Users After Subcutaneous Vaccination Compared to Natural Infection.
    J Med Virol. 2025;97:e70498.
    PubMed     Abstract available
    
    
    June 2025
22. ZHAO X, Lu C, Wang Z, Qiao F, et al
    Development of a HiFi-LAMP Assay for Detection of Human Pegivirus Type 1 RNA.
    J Med Virol. 2025;97:e70423.
    PubMed     Abstract available
    
    
    
23. TIEOSAPJAROEN W, Tran A, Maisano M, Kim CM, et al
    Trend and Associated Factors for Late and Advanced HIV Diagnoses in 2011-2022 in Melbourne, Australia.
    J Med Virol. 2025;97:e70430.
    PubMed     Abstract available
    
    
    
24. DE OLIVEIRA KG, Vasconcelos MPA, Ton JT, Uehara SNO, et al
    A Comprehensive Molecular and Serological Investigation of Hepatitis A Virus Among Patients With Suspected Acute Hepatitis: A Brazilian Study.
    J Med Virol. 2025;97:e70449.
    PubMed     Abstract available
    
    
    May 2025
25. YANG T, Lei H, Li J, Liang Y, et al
    A Visual Nomogram Survival Prediction Model in Acquired Immune Deficiency Syndrome (AIDS)-Related Diffuse Large B-Cell Lymphoma.
    J Med Virol. 2025;97:e70359.
    PubMed     Abstract available
    
    
    
26. KILLER A, Gliga S, Jensen BO, Park P, et al
    Functional Cure of Hepatitis B and D Coinfection After ART Nonadherence in a Person With HIV.
    J Med Virol. 2025;97:e70375.
    PubMed    
    
    
    
27. ALICE M, Fabienne T, Jean-Christophe P
    Genetic Evolution Between HIV-1 Groups M and O: HIV-1/MO Recombinant Forms.
    J Med Virol. 2025;97:e70358.
    PubMed     Abstract available
    
    
    
28. MARONEY KJ, Ye Y, Sudenga SL, Diffalha SA, et al
    Higher Expression of HPV16 Derived E7_LI Transcript Observed in Men With HIV and Recurrent Anal Cancer.
    J Med Virol. 2025;97:e70371.
    PubMed     Abstract available
    
    
    
29. JARY A, van der Zee RP, Jongen V, Ter Braak TJ, et al
    Molecular Insights Into the Natural History of Anal HSIL.
    J Med Virol. 2025;97:e70397.
    PubMed     Abstract available
    
    
    April 2025
30. TADESE BK, You X, Ndao T, Tota JE, et al
    The Burden of HPV Infections and HPV-Related Diseases Among People With HIV: A Systematic Literature Review.
    J Med Virol. 2025;97:e70274.
    PubMed     Abstract available
    
    
    
31. BANGWEN E, Berens-Riha N, de Vrij N, Ceulemans A, et al
    No Distinct Cytokine, Chemokine, and Growth Factor Blood Profile Associated With Monkeypox Virus Clade IIb Infected Patients.
    J Med Virol. 2025;97:e70320.
    PubMed     Abstract available
    
    
    
32. WEI Q, Chen L, Yin Y, Pai M, et al
    Analysis of Blood Microbiome From People Living With HIV and Donors by 16S rRNA Metagenomic Sequencing.
    J Med Virol. 2025;97:e70341.
    PubMed     Abstract available
    
    
    
33. DEMIRDJIAN S, Naik V, Margot N, Falkard B, et al
    Phenotypic Characterization of Replication-Impaired Lenacapavir-Resistant HIV Clinical Isolates.
    J Med Virol. 2025;97:e70340.
    PubMed     Abstract available
    
    
    March 2025
34. JIANG Q, Zhou Z, Du X, Li Y, et al
    Novel Function of NUP153 in HNF4alpha Transcriptional Upregulation Contributes to Promoting HBV Replication.
    J Med Virol. 2025;97:e70256.
    PubMed     Abstract available
    
    
    
35. JIN Q, Zhou M, Sun M, Ning B, et al
    Global Temporal Trends in Mother-to-Child Transmission Disease Incidence Among Women of Child-Bearing Age: An Analysis of Global Burden of Disease Study 2021 Data.
    J Med Virol. 2025;97:e70283.
    PubMed     Abstract available
    
    
    
36. LIU S, Liu P, Lu Q, Shen Y, et al
    The Compensatory Effect of S375F on S371F Is Vital for Maintaining the Infectivity of SARS-CoV-2 Omicron Variants.
    J Med Virol. 2025;97:e70242.
    PubMed     Abstract available
    
    
    
37. AMEGASHIE EA, Kwayisi-Darkwah CK, Adusei-Poku M, Sikeola RO, et al
    Lipid Peroxidation and Glutathione Levels Among People Living With HIV Co-infected With Human Coronaviruses in Ghana.
    J Med Virol. 2025;97:e70301.
    PubMed     Abstract available
    
    
    
38. SEBASTIAO CS, Bathy J, Nhampossa T, Santos A, et al
    Susceptibility to Lenacapavir Among Newly Diagnosed HIV-Positive Patients Followed Up in Mozambique That Presented With Primary Antiretroviral Resistance to Other Classes.
    J Med Virol. 2025;97:e70317.
    PubMed     Abstract available
    
    
    
39. ZHANG X, Wu S, Lin Y, Zhang W, et al
    Development of an Assay Evaluating the Inducible HIV-1 Latent Reservoir Based on Reverse Transcription Droplet Digital PCR for Unspliced/Intact Viral RNA.
    J Med Virol. 2025;97:e70295.
    PubMed     Abstract available
    
    
    
40. BETTUZZI T, Lebbe C, Grolleau C
    Modern Approach to Manage Patients With Kaposi Sarcoma.
    J Med Virol. 2025;97:e70294.
    PubMed     Abstract available
    
    
    February 2025
41. LUZ E, Marques M, Arriaga MB, Campos LM, et al
    Risk Factors for Viral Coinfections in Blood Donors in Bahia, Brazil.
    J Med Virol. 2025;97:e70186.
    PubMed     Abstract available
    
    
    
42. SILVESTRE C, Tuaillon E, Duroyon MM, Abrantes M, et al
    NK Count and Natural Cytotoxicity in Immune Nonresponders Versus Responders Living With HIV.
    J Med Virol. 2025;97:e70170.
    PubMed     Abstract available
    
    
    
43. SHARMA D, Rai M, Singh A, Gaur R, et al
    Fullerene (C(60) & C(70))-Meso-Tris-4-Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild-Type and Drug-Resistant HIV-1 Clades B and C.
    J Med Virol. 2025;97:e70181.
    PubMed     Abstract available
    
    
    
44. TYRBERG T, Hagberg L, Nilsson S, Grahn A, et al
    Incidence and Risk Factors for Varicella-Zoster Virus-Associated Central Nervous System Infections: A Nationwide Swedish Retrospective Case-Control Study.
    J Med Virol. 2025;97:e70166.
    PubMed     Abstract available
    
    
    
45. 
    Correction to "Fullerene (C60 & C70)-Meso-Tris-4-Carboxyphenyl Porphyrin Dyads Inhibit Entry of Wild-Type and Drug-Resistant HIV-1 Clades B and C".
    J Med Virol. 2025;97:e70232.
    PubMed    
    
    
    
46. LI K, Luo L, Ji Y, Zhang Q, et al
    Urgent Focus on the Surgical Risks of People Living With HIV: A Systematic Review and Meta-Analysis.
    J Med Virol. 2025;97:e70260.
    PubMed     Abstract available
    
    
    
47. HOTA M, Wondeu ALD, Abakar MF, Dezoumbe K, et al
    Integrated Seroprevalence and Genome-Based Study of SARS-CoV-2 Viral Strains in N'Djamena: Insights Into Chad's COVID-19 Epicenter.
    J Med Virol. 2025;97:e70234.
    PubMed     Abstract available
    
    
    
48. LU Z, Dong B, Yao P, Huang Y, et al
    Characteristics of Human Papillomavirus Prevalence and Infection Patterns Among Women Aged 35-65 in Fujian Province, China: A Nine-Year Retrospective Observational Study.
    J Med Virol. 2025;97:e70238.
    PubMed     Abstract available
    
    
    January 2025
49. XIAO Q, He S, Wang C, Liu Y, et al
    Urgent Call for Attention to HIV-Associated Lymphoma: After AIDS 2024, the 25th International AIDS Conference.
    J Med Virol. 2025;97:e70159.
    PubMed    
    
    
    
50. ZANET E, Taborelli M, Tirelli U, Diez-Martin J, et al
    Long-Term Clinical Outcomes After Autologous Hematopoietic Stem Cell Transplantation in 49 Individuals Living With HIV (PLWH) and Affected by High-Risk or Relapsed Lymphoma: A European Experience of Continued Relevance for PLWH.
    J Med Virol. 2025;97:e70165.
    PubMed     Abstract available
    
    
    December 2024
51. WANG J, Ni S, Chen Q, Wang C, et al
    Discovery of a Novel Public Antibody Lineage Correlated With Inactivated SARS-CoV-2 Vaccine and the Resultant Neutralization Activity.
    J Med Virol. 2024;96:e70073.
    PubMed     Abstract available
    
    
    
52. STICH M, Magalhaes VG, Burger F, Garbade SF, et al
    Elevated Soluble ACE2 Activity in Children and Adults After SARS-CoV-2 Exposure Irrespective of Laboratory-Confirmed Infection.
    J Med Virol. 2024;96:e70098.
    PubMed     Abstract available
    
    
    
53. SHABIL M, Khatib MN, Ballal S, Bansal P, et al
    Effectiveness of Tecovirimat in Mpox Cases: A Systematic Review of Current Evidence.
    J Med Virol. 2024;96:e70122.
    PubMed     Abstract available
    
    
    
54. CHEN X, Chen R, Wen L, Qin T, et al
    Long Noncoding RNA LINC02453 Inhibits HIV-1 Replication by Binding With SEC13 to Regulate the Viral Productive Cycle.
    J Med Virol. 2024;96:e70116.
    PubMed     Abstract available
    
    
    
55. ZHANG J, Shao S, Chen X, Wang S, et al
    Genome-Wide Association Study of Persistent Anal Human Papillomavirus Infection Among HIV-Positive Males in Taizhou, China: A Cohort Study.
    J Med Virol. 2024;96:e70126.
    PubMed     Abstract available
    
    
    
56. LIN W, He Y, Gu F, Hu F, et al
    Hepatic Flare Following Effective Antiretroviral Therapy Is Associated With HBsAg Seroclearance in HBV/HIV-1 Co-Infection.
    J Med Virol. 2024;96:e70114.
    PubMed     Abstract available
    
    
    
57. CHEN F, Li D, Tang H, Ge L, et al
    Estimates of HIV Incidence, Prevalence, and Mortality in China 2018.
    J Med Virol. 2024;96:e70048.
    PubMed     Abstract available
    
    
    November 2024
58. GUIRAUD V, Naizet A, Khan H, Benhafoun G, et al
    Fourth-Generation HIV Rapid Tests: Enhanced Sensitivity and Reduced Diagnostic Window for HIV-1 Primary Infection Screening.
    J Med Virol. 2024;96:e70044.
    PubMed     Abstract available
    
    
    
59. LI X, Shi H, Shi H, Xu Y, et al
    Transmission Network and Phylogenetic Analysis Highlight the Role of Suburban Population in HIV-1 Transmission Among Older Adults in Nanjing, Jiangsu Province, China.
    J Med Virol. 2024;96:e70035.
    PubMed     Abstract available
    
    
    
60. LIU B, Zhang Q
    Systemic Immune-Inflammation-Based Biomarker and Fragility Fractures in People Living With HIV: A 10-Year Follow-Up Cohort Study in China.
    J Med Virol. 2024;96:e70052.
    PubMed     Abstract available
    
    
    
61. WANG N, Lin Q, Fan H, Wang Y, et al
    BIC/FTC/TAF Benefits People Living With HIV After Omicron Breakthrough Infection in Shortening Duration of Symptoms, Enhancing Specific Immune Response and Increasing Total CD4 Cells.
    J Med Virol. 2024;96:e70036.
    PubMed     Abstract available
    
    
    
62. ZHAO H, He Y, Ling X, Hou H, et al
    Profiles of Lymphocyte Subtypes in HIV-Infected People With Different Immunologic Responses to Antiretroviral Therapy.
    J Med Virol. 2024;96:e70081.
    PubMed     Abstract available
    
    
    October 2024
63. KUHN D, Heinen N, Sutter K, Herrmann ST, et al
    Divergent autoantibody and cytokine levels in COVID-19 sepsis patients influence survival.
    J Med Virol. 2024;96:e29935.
    PubMed     Abstract available
    
    
    
64. LV S, Lan Y, He Y, Li Q, et al
    Pretreatment drug resistance among people living with HIV from 2018 to 2022 in Guangzhou, China.
    J Med Virol. 2024;96:e29937.
    PubMed     Abstract available
    
    
    
65. CHAIX ML, Terracol L, Nere ML, Stefic K, et al
    Susceptibility to lenacapavir, fostemsavir and broadly neutralizing antibodies in French primary HIV-1 infected patients in 2020-2023.
    J Med Virol. 2024;96:e29948.
    PubMed     Abstract available
    
    
    
66. ALIDJINOU EK
    Comments on "High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and suboptimal adherence".
    J Med Virol. 2024;96:e29950.
    PubMed    
    
    
    
67. ANDREATTA K, D'Antoni ML, Chang S, Parvangada A, et al
    High efficacy of bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) in Black adults in the United States, including those with pre-existing HIV resistance and suboptimal adherence.
    J Med Virol. 2024;96:e29899.
    PubMed     Abstract available
    
    
    
68. VELLAS C, Doudou A, Mohamed S, Raymond S, et al
    Comparison of short-read and long-read next-generation sequencing technologies for determining HIV-1 drug resistance.
    J Med Virol. 2024;96:e29951.
    PubMed     Abstract available
    
    
    September 2024
69. LO VT, Lim HA, Jang SS, Kim MC, et al
    N121T and N121S substitutions on the SARS-CoV-2 spike protein impact on serum neutralization.
    J Med Virol. 2024;96:e29871.
    PubMed     Abstract available
    
    
    
70. GAY L, Desquiret-Dumas V, Nagot N, Rapenne C, et al
    Long-term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved.
    J Med Virol. 2024;96:e29886.
    PubMed     Abstract available
    
    
    
71. PAN D, Mohamed B, Gupta A, Arshad Z, et al
    Clinical and molecular epidemiology of enterovirus infections in cerebrospinal fluid samples, 2019-2023.
    J Med Virol. 2024;96:e29924.
    PubMed     Abstract available
    
    
    August 2024
72. LI J, Lv J, Yu F, Zhang Y, et al
    Temporal changes in plasma metabolic signatures to predict immune response of antiretroviral therapy among people living with HIV.
    J Med Virol. 2024;96:e29798.
    PubMed     Abstract available
    
    
    
73. MONTI B, Soria A, Saladini F, Lapadula G, et al
    Regaining virological suppression in a woman living with a six-class resistant HIV by combining injectable antiretroviral drugs guided by genotypic and phenotypic tests.
    J Med Virol. 2024;96:e29832.
    PubMed    
    
    
    
74. GUPTA A, Righi E, Konnova A, Sciammarella C, et al
    Interleukin-2-mediated CD4 T-cell activation correlates highly with effective serological and T-cell responses to SARS-CoV-2 vaccination in people living with HIV.
    J Med Virol. 2024;96:e29820.
    PubMed     Abstract available
    
    
    
75. SUTERIO DG, Hunter JR, Tenore SB, Pimentel SR, et al
    People living with HIV co-infected with the Kaposi Sarcoma-associated Herpes Virus have a distinct HIV Tat profile and higher rates of antiretroviral virologic failure, more evident among those with Kaposi's sarcoma.
    J Med Virol. 2024;96:e29840.
    PubMed     Abstract available
    
    
    
76. HEHE Z, Minna Z, Qin F, Tielin N, et al
    Application of molecular epidemiology in revealing HIV-1 transmission network and recombination patterns in Tianjin, China.
    J Med Virol. 2024;96:e29824.
    PubMed     Abstract available
    
    
    
77. WANG Z, Wang W, Gao Z, Gao H, et al
    Structure-based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug-like profiles.
    J Med Virol. 2024;96:e29830.
    PubMed     Abstract available
    
    
    
78. PIETROLUONGO E, Luciano A, Peddio A, Buonaiuto R, et al
    Exploring the interplay between Kaposi's sarcoma and SARS-CoV-2 infection: A case series and systematic review.
    J Med Virol. 2024;96:e29849.
    PubMed     Abstract available
    
    
    
79. RIZZO A, Moschese D, Salari F, Giacomelli A, et al
    Anal HPV prevalence in individuals with and without other concomitant sexually transmitted infections.
    J Med Virol. 2024;96:e29852.
    PubMed     Abstract available
    
    
    
80. PASSERINI S, Fracella M, Benvenuto D, Bugani G, et al
    High rates of anal Merkel Cell Polyomavirus and HPV co-infection among people living with HIV.
    J Med Virol. 2024;96:e29883.
    PubMed     Abstract available
    
    
    
81. FOURY A, Saunier A, Taverniers A, Pinet N, et al
    The relevance of ultradeep sequencing for low HIV-1 viral loads and proviruses in the clinical setting.
    J Med Virol. 2024;96:e29870.
    PubMed     Abstract available
    
    
    July 2024
82. MCCLURE CP, Kean K, Reid K, Mayne R, et al
    Reconstruction of the historic time course of blood-borne virus contamination of clotting factor concentrates, 1974-1992.
    J Med Virol. 2024;96:e29774.
    PubMed     Abstract available
    
    
    
83. LIANG Z, Lin C, Huo D, Yang Y, et al
    First detection of multiple cases related to CV-A16 strain of B1c clade in Beijing in 2022.
    J Med Virol. 2024;96:e29796.
    PubMed     Abstract available
    
    
    
84. FANG T, Liu L, Mao S, Jiang Z, et al
    Association between virus infection and periodontitis: Evidence from the National Health and Nutrition Examination Survey 2009-2014.
    J Med Virol. 2024;96:e29784.
    PubMed     Abstract available
    
    
    
85. ZHANG Y, Geng M, Xing Y, Ren X, et al
    Improvement and exacerbation of multiple disparities in sexually transmitted infections among children and adolescents aged 6-22 years: An analysis of national surveillance data from 2013 to 2021.
    J Med Virol. 2024;96:e29808.
    PubMed     Abstract available
    
    
    
86. MATSCHKE J, Hartmann K, Pfefferle S, Wang Y, et al
    Inefficient tissue immune response against MPXV in an immunocompromised mpox patient.
    J Med Virol. 2024;96:e29811.
    PubMed     Abstract available
    
    
    
87. YAN H, Wu H, Li S, Wang J, et al
    The origin and spread of HIV-1 CRF59_01B epidemic in China: A molecular network and phylogeographic analysis.
    J Med Virol. 2024;96:e29799.
    PubMed     Abstract available
    
    
    June 2024
88. LI J, Xie DD, Cui HL, Yue C, et al
    Trends in the burden and determinants of HIV in the Asia-Pacific region (1990-2019): An age-period-cohort analysis of the 2019 Global Burden of Disease Study.
    J Med Virol. 2024;96:e29724.
    PubMed     Abstract available
    
    
    
89. CHEN R, Fu Y, Li D, Wang S, et al
    Proteomic analysis of plasma in healthy adults receiving recombinant vaccinia virus provides novel insights into HIV-1 neutralizing antibodies.
    J Med Virol. 2024;96:e29749.
    PubMed     Abstract available
    
    
    
90. MOOKO T, Bisiwe FB, Chikobvu P, Morobadi MD, et al
    The prevalence of HIV resistance mutations and their influence on the shedding of HIV-1 into peritoneal dialysis effluent.
    J Med Virol. 2024;96:e29734.
    PubMed     Abstract available
    
    
    
91. GU F, Zeng K, Lan X, He Y, et al
    Measuring HBV pregenomic RNA may be a potential biomarker to determine HBV functional cure in HIV/HBV-co-infected patients with HBsAg loss.
    J Med Virol. 2024;96:e29762.
    PubMed     Abstract available
    
    
    May 2024
92. LIRA GS, Ota VA, Melo MQS, Castineiras ACP, et al
    Mpox outbreak in Rio de Janeiro, Brazil: A translational approach.
    J Med Virol. 2024;96:e29621.
    PubMed     Abstract available
    
    
    
93. RALLON N, Jimenez-Carretero D, Restrepo C, Ligos JM, et al
    A specific natural killer cells phenotypic signature associated to long term elite control of HIV infection.
    J Med Virol. 2024;96:e29646.
    PubMed     Abstract available
    
    
    
94. MATUSALI G, Mazzotta V, Meschi S, Colavita F, et al
    JN.1 neutralizing antibody titers after XBB.1.5 monovalent vaccine boost in healthcare workers and people with HIV.
    J Med Virol. 2024;96:e29631.
    PubMed    
    
    
    
95. RZYMSKI P, Zarebska-Michaluk D, Parczewski M, Genowska A, et al
    The burden of infectious diseases throughout and after the COVID-19 pandemic (2020-2023) and Russo-Ukrainian war migration.
    J Med Virol. 2024;96:e29651.
    PubMed     Abstract available
    
    
    
96. HWANG JH, Hwang JH
    Is a 2-week regimen of tecovirimat sufficient for the treatment of Mpox (monkeypox) in advanced HIV patients with a low CD4 cell count?
    J Med Virol. 2024;96:e29617.
    PubMed    
    
    
    April 2024
97. KIM M, Kim E
    Effective vaccination strategies for human papillomavirus (HPV) infection and cervical cancer based on the mathematical model with a stochastic process.
    J Med Virol. 2024;96:e29558.
    PubMed     Abstract available
    
    
    
98. JIANG X, Gao Z, Sharma PP, Kumar S, et al
    Discovery of low-molecular-weight phenylalanine derivatives as novel HIV capsid modulators with improved antiretroviral activity and metabolic stability.
    J Med Virol. 2024;96:e29594.
    PubMed     Abstract available
    
    
    
99. MATUSALI G, Vergori A, Cimini E, Mariotti D, et al
    Poor durability of the neutralizing response against XBB sublineages after a bivalent mRNA COVID-19 booster dose in persons with HIV.
    J Med Virol. 2024;96:e29598.
    PubMed     Abstract available
    
    
    
100. LI Y, Zhang X, Huang Y, Gao L, et al
     The prevalence of Human Immunodeficiency Virus infection among voluntary blood donors in mainland China: A systematic review and meta-analysis.
     J Med Virol. 2024;96:e29599.
     PubMed     Abstract available
     
     
     March 2024
101. XIAO J, Luo Y, Li Y, Yao X, et al
     The characteristics of BCR-CDR3 repertoire in COVID-19 patients and SARS-CoV-2 vaccinated volunteers.
     J Med Virol. 2024;96:e29488.
     PubMed     Abstract available
     
     
     
102. XIE M, Wang Z, Zhao F, Li Y, et al
     Structure-based design of diarylpyrimidines and triarylpyrimidines as potent HIV-1 NNRTIs with improved metabolic stability and drug resistance profiles.
     J Med Virol. 2024;96:e29502.
     PubMed     Abstract available
     
     
     
103. CORMA-GOMEZ A, Cabello A, Orviz E, Morante-Ruiz M, et al
     Long or complicated mpox in patients with uncontrolled HIV infection.
     J Med Virol. 2024;96:e29511.
     PubMed     Abstract available
     
     
     
104. WANG Z
     Novel diarylpyrimidine subtypes as HIV-1 nonnucleoside reverse transcriptase inhibitors with improved resistance profile.
     J Med Virol. 2024;96:e29553.
     PubMed    
     
     
     
105. TRUNFIO M, Tang B, Okwuegbuna O, Iudicello JE, et al
     Longitudinal analysis of CSF HIV RNA in untreated people with HIV: Identification of CSF controllers.
     J Med Virol. 2024;96:e29550.
     PubMed     Abstract available
     
     
     
106. FARAONE JN, Wang X, Qu P, Zheng YM, et al
     Neutralizing antibody response to SARS-CoV-2 bivalent mRNA vaccine in SIV-infected rhesus macaques: Enhanced immunity to XBB subvariants by two-dose vaccination.
     J Med Virol. 2024;96:e29520.
     PubMed     Abstract available
     
     
     
107. KASSAM P, El-Zein M, Laurie C, Tota JE, et al
     Use of a carrageenan-based gel had no impact on anal HPVs 16 and 18 viral loads in gay, bisexual, and other men who have sex with men.
     J Med Virol. 2024;96:e29562.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO HIV Infection is free of charge.